Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
26,920,427
-
Share change
-
+3,388,544
-
Total reported value
-
$792,304,929
-
Price per share
-
$29.46
-
Number of holders
-
79
-
Value change
-
+$102,643,853
-
Number of buys
-
54
-
Number of sells
-
23
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q2 2021
As of 30 Jun 2021,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,920,427 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., JENNISON ASSOCIATES LLC, CANADA PENSION PLAN INVESTMENT BOARD, Sumitomo Mitsui Trust Holdings, Inc., AMERIPRISE FINANCIAL INC, Nikko Asset Management Americas, Inc., and GILDER GAGNON HOWE & CO LLC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.